293 related articles for article (PubMed ID: 27723802)
1. NF-κB-Mediated CCL20 Reigns Dominantly in CXCR2-Driven Ovarian Cancer Progression.
Ignacio RM; Kabir SM; Lee ES; Adunyah SE; Son DS
PLoS One; 2016; 11(10):e0164189. PubMed ID: 27723802
[TBL] [Abstract][Full Text] [Related]
2. CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-κB activation via EGFR-transactivated Akt signaling.
Dong YL; Kabir SM; Lee ES; Son DS
PLoS One; 2013; 8(12):e83789. PubMed ID: 24376747
[TBL] [Abstract][Full Text] [Related]
3. GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade.
Yung MM; Tang HW; Cai PC; Leung TH; Ngu SF; Chan KK; Xu D; Yang H; Ngan HY; Chan DW
Theranostics; 2018; 8(5):1270-1285. PubMed ID: 29507619
[TBL] [Abstract][Full Text] [Related]
4. CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis.
Yang G; Rosen DG; Liu G; Yang F; Guo X; Xiao X; Xue F; Mercado-Uribe I; Huang J; Lin SH; Mills GB; Liu J
Clin Cancer Res; 2010 Aug; 16(15):3875-86. PubMed ID: 20505188
[TBL] [Abstract][Full Text] [Related]
5. Chemokine-cytokine cross-talk. The ELR+ CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-kappa B pathway.
Chandrasekar B; Melby PC; Sarau HM; Raveendran M; Perla RP; Marelli-Berg FM; Dulin NO; Singh IS
J Biol Chem; 2003 Feb; 278(7):4675-86. PubMed ID: 12468547
[TBL] [Abstract][Full Text] [Related]
6. Keratinocyte chemoattractant (KC)/human growth-regulated oncogene (GRO) chemokines and pro-inflammatory chemokine networks in mouse and human ovarian epithelial cancer cells.
Son DS; Parl AK; Rice VM; Khabele D
Cancer Biol Ther; 2007 Aug; 6(8):1302-12. PubMed ID: 17712227
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 5- and lymphotoxin beta receptor-dependent epithelial Ccl20 expression involves the same NF-kappaB binding site but distinct NF-kappaB pathways and dynamics.
Sirard JC; Didierlaurent A; Cayet D; Sierro F; Rumbo M
Biochim Biophys Acta; 2009 May; 1789(5):386-94. PubMed ID: 19303953
[TBL] [Abstract][Full Text] [Related]
8. Astrocyte-derived CCL20 reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-κB signaling pathway.
Jin P; Shin SH; Chun YS; Shin HW; Shin YJ; Lee Y; Kim D; Nam DH; Park JW
Oncogene; 2018 Jun; 37(23):3070-3087. PubMed ID: 29535421
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 beta transactivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancer.
Lee CH; Syu SH; Liu KJ; Chu PY; Yang WC; Lin P; Shieh WY
Oncotarget; 2015 Nov; 6(36):38866-80. PubMed ID: 26462152
[TBL] [Abstract][Full Text] [Related]
10. Biphasic Ccl20 regulation by Toll-like receptor 9 through the activation of ERK-AP-1 and non-canonical NF-κB signaling pathways.
Dutta P; Ta A; Thakur BK; Dasgupta N; Das S
Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3365-3377. PubMed ID: 27590109
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling.
Wang D; Yang L; Yu W; Wu Q; Lian J; Li F; Liu S; Li A; He Z; Liu J; Sun Z; Yuan W; Zhang Y
J Immunother Cancer; 2019 Aug; 7(1):215. PubMed ID: 31395078
[TBL] [Abstract][Full Text] [Related]
12. Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation.
Taki M; Abiko K; Baba T; Hamanishi J; Yamaguchi K; Murakami R; Yamanoi K; Horikawa N; Hosoe Y; Nakamura E; Sugiyama A; Mandai M; Konishi I; Matsumura N
Nat Commun; 2018 Apr; 9(1):1685. PubMed ID: 29703902
[TBL] [Abstract][Full Text] [Related]
13. CCL20 is elevated during obesity and differentially regulated by NF-κB subunits in pancreatic β-cells.
Burke SJ; Karlstad MD; Regal KM; Sparer TE; Lu D; Elks CM; Grant RW; Stephens JM; Burk DH; Collier JJ
Biochim Biophys Acta; 2015 Jun; 1849(6):637-52. PubMed ID: 25882704
[TBL] [Abstract][Full Text] [Related]
14. Levo-corydalmine alleviates vincristine-induced neuropathic pain in mice by inhibiting an NF-kappa B-dependent CXCL1/CXCR2 signaling pathway.
Zhou L; Hu Y; Li C; Yan Y; Ao L; Yu B; Fang W; Liu J; Li Y
Neuropharmacology; 2018 Jun; 135():34-47. PubMed ID: 29518397
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of chemokine signatures elicited by EGF and TNF in ovarian cancer cells.
Son DS; Kabir SM; Dong Y; Lee E; Adunyah SE
J Inflamm (Lond); 2013 Jun; 10(1):25. PubMed ID: 23800251
[TBL] [Abstract][Full Text] [Related]
16. Macrophage-inflammatory protein-3alpha/CCL-20 is transcriptionally induced by the iron chelator desferrioxamine in human mononuclear phagocytes through nuclear factor (NF)-kappaB.
Varesio L; Battaglia F; Raggi F; Ledda B; Bosco MC
Mol Immunol; 2010 Jan; 47(4):685-93. PubMed ID: 19939449
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of tumor suppressor p53 on proinflammatory chemokine expression in ovarian cancer cells by reducing proteasomal degradation of IκB.
Son DS; Kabir SM; Dong YL; Lee E; Adunyah SE
PLoS One; 2012; 7(12):e51116. PubMed ID: 23300534
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori induces CCL20 expression.
Tomimori K; Uema E; Teruya H; Ishikawa C; Okudaira T; Senba M; Yamamoto K; Matsuyama T; Kinjo F; Fujita J; Mori N
Infect Immun; 2007 Nov; 75(11):5223-32. PubMed ID: 17724069
[TBL] [Abstract][Full Text] [Related]
19. Chemokine CCL20 promotes the paclitaxel resistance of CD44
Chen M; Su J; Feng C; Liu Y; Zhao L; Tian Y
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278466
[TBL] [Abstract][Full Text] [Related]
20. NLRP6 exerts a protective role via NF-kB with involvement of CCL20 in a mouse model of alcoholic hepatitis.
Ji X; Li L; Lu P; Li X; Tian D; Liu M
Biochem Biophys Res Commun; 2020 Jul; 528(3):485-492. PubMed ID: 32507279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]